Enhanced Mesenchymal Stromal Cells or Erythropoietin Provide Long-Term Functional Benefit After Neonatal Stroke. Larpthaveesarp A, Pathipati P, Ostrin S, Rajah A, et al. Stroke 2020 Dec 22:STROKEAHA120031191. doi: 10.1161/STROKEAHA.120.031191.

Read + Share

Amedeo Smart

Independent Medical Education

Larpthaveesarp A, Pathipati P, Ostrin S, Rajah A, et al. Enhanced Mesenchymal Stromal Cells or Erythropoietin Provide Long-Term Functional Benefit After Neonatal Stroke. Stroke 2020 Dec 22:STROKEAHA120031191. doi: 10.1161/STROKEAHA.120.031191.
PMID: 33349013